Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ALLERGAN INC [US]”

7 pharma patents match "ALLERGAN INC [US]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "ALLERGAN INC [US]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “ALLERGAN INC [US]” · 30,257 patents in full index Clear search

  1. US 2014356438

    PERIPHERALLY ADMINISTERED VISCOUS FORMULATIONS

    ALLERGAN INC [US] · Granted Dec 4, 2014 · Expires Nov 29, 2034

    granted

  2. US 2013209398

    CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE

    ALLERGAN INC [US] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted

  3. US 2011062165

    BALANCED INDIVIDUAL DINING PLATE

    ALLERGAN INC [US] · Granted Mar 17, 2011 · Expires Mar 12, 2031

    granted

  4. US 2010204127

    USE OF A BOTULINUM NEUROTOXIN TO ALLEVIATE VARIOUS DISORDERS

    ALLERGAN INC [US] · Granted Aug 12, 2010 · Expires Aug 7, 2030

    granted

  5. US 2009239858

    THERAPEUTIC AMIDES

    ALLERGAN INC [US] · Granted Sep 24, 2009 · Expires Sep 19, 2029

    granted

  6. US 2008241252

    METHODS AND COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION TO TREAT OCULAR CONDITIONS

    ALLERGAN INC [US] · Granted Oct 2, 2008 · Expires Sep 27, 2028

    granted

  7. US 2002161051

    (2-hydroxy)ethyl-thioureas useful as modulators of alpha2B adrenergic receptors

    ALLERGAN INC [US] · Granted Oct 31, 2002 · Expires Oct 26, 2022

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.